Načítá se...
Orally administered endoxifen inhibits tumor growth in melanoma-bearing mice
Endoxifen, an active metabolite of tamoxifen, has been shown to be an effective anti-estrogenic agent in estrogen receptor-positive breast cancer patients. In melanoma, estrogen receptor expression is shown to be associated with disease progression. However, the therapeutic benefit of endoxifen in m...
Uloženo v:
| Vydáno v: | Cell Mol Biol Lett |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5751858/ https://ncbi.nlm.nih.gov/pubmed/29308069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s11658-017-0068-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|